From these results, compared with the normal control group, CAPN10, CASP1, and RPS6KB1 were downregulated in the AD group, while ATG16L2, BAK1, RAB24, RGS19, ULK2, and WDFY3 were upregulated in the AD group. This evidence concerns the gene WDFY3 and Alzheimer disease.